Introduction {#sec1-1}
============

Cervical cancer is the fourth most common cancer among females worldwide with an estimated 570,000 new cases in 2018 representing 6.6% of all female cancers (GLOBOCAN, 2018), with the vast majority occurring in developing countries (Abudukadeer et al., 2015). In the Kingdom of Saudi Arabia (KSA), the most recent Saudi Cancer Registry (SCR) report showed there were 117 new cases of cervical cancer diagnosed in 2014, accounting for 1.8% of diagnosed cancer cases in females and making it the 15th most frequent cancer in the female Saudi population (Annual Cancer Incidence Report for Saudi Cancer Registry, 2017).

Although the incidence of cervical cancer in KSA is very low, the involvement of human papilloma virus (HPV) infection in this malignancy is comparable to the rest of the world with HPV-16 and HPV-18. Cervical cancer vaccination is expected to protect against more than two-thirds of cervical cancer in KSA (Alsbeih, 2014).

National Health Services (NHS) in the United Kingdom (UK) concluded that, in any case of cancer cervix developed at the average age of 46--50, this may entail that carcinogenesis had started 20 years prior, so cervical screening now starts at 25 years of age (Sasieni et al., 2009; Cervical screening, 2015). Cervical screening in females aged 20--24 has little or no impact on rates of invasive cervical cancer up to age 30, while screening older females leads to a substantial reduction in incidence and mortality from cervical cancer (Sasieni et al., 2009). Although a localized Saudi cervical screening program was established in 2009 to promote routine screening for cervical cancer with HPV testing for all females above the age of 30 who have been married for at least three years, Pap smear screening is still performed on an opportunistic basis in Saudi Arabia (Al-Kadri et al., 2015).

The United Kingdom's cervical screening program changed its screening method from the conventional Pap method to liquid-based cytology (LBC) in 2008 (Liptak and Barnetson, 2012). Liquid cytology produced a significantly higher yield of histologic high-grade lesions compared with conventional Pap smears (Strander et al., 2007). While other studies showed significant improvements in achieving the target diagnosis over time for squamous dysplasia using both modalities (Marquart et al., 2015), both types of cytological screening are considered acceptable methods of cervical cancer screening by the American College of Obstetricians and Gynecologists (ACOG Committee on Practice Bulletins-Gynecology, 2009). To unify systems of reporting cervical/vaginal cytological diagnosis, the National Cancer Institute Workshop proposed the Bethesda System of nomenclature in 1988 (Al-Kadri et al., 2015).

No similar recent study has been performed in the Madinah region of KSA that allows a clear view of the prevalence of cervical cancer and its characteristics. Therefore, this study aimed to explore the cytopathological pattern of cervical Pap smears in the Madinah region of KSA and to assess the clinical and personal characteristics of patients who were diagnosed with abnormal Pap smears.

Materials and Methods {#sec1-2}
=====================

This retrospective case-control study was conducted in the Departments of Obstetrics and Gynecology, and Histopathology at the Maternity and Children Hospital (MCH), Madinah, KSA from January 2013 to December 2016. Gynecologists collected the smear utilizing a cytobrush from the uterine cervix transformation zone. The cytobrush was then placed in a liquid-based cytology transport preservative, SurePath. Smears were collected from patients who attended gynecology clinics complaining about different symptoms. Few patients came intentionally without symptoms for screening purposes. Smears were evaluated by histopathologists and were diagnosed and reported according to the Bethesda System III for Reporting Cervical Cytology 2001.

All females of all ages and nationalities who had their Pap smears performed between January 2013 and December 2015 were included in the study, and all reports gave the complete diagnosis despite non-uniformities in the pattern; unsatisfactory Pap smears and repeated smears after short intervals with the same diagnosis were excluded.

A total of 1,594 cases were reviewed for the study with 38 cases yielding abnormal epithelial lesions, which were considered study cases (group I or case); 77 normal pap smears were considered the control group (group II or control) and were selected randomly from the normal smears throughout the whole three years of the study. In addition, 25, 25, and 27 normal smears were selected from the years 2013, 2014, and 2015, respectively, based on patients' laboratory numbers. Paper and electronic medical records of all patients in both groups were reviewed, and Pap smear results, history, clinical data, and demographic data were collected. Three main categories of smear cytology were identified: normal, abnormal, and unsatisfactory. The abnormal category included epithelial cell lesions (ECL) and no intraepithelial lesion or malignancy (NILM). ECL included high-grade squamous intraepithelial lesion (HSIL), low-grade squamous intraepithelial lesion (LSIL), atypical squamous cells of unknown significance(ASCUS), squamous cell carcinoma (SCC), atypical glandular (AGC), and endocervical adenocarcinoma (ECA). No intraepithelial lesion or malignancy included benign categories: inflammation, repair, atrophic, and hormonal changes. Smears obscured by blood and inflammation, smears that were acellular, and those just showing endocervical cells were all allocated within the unsatisfactory category. All the statistical analysis was done using the Statistical Package for the Social Sciences (SPSS) version 20 (SPSS Inc., Chicago, USA).

Ethical approval for the study was obtained from the Committee of Scientific Research Ethics at MCH. Patients' demographic and clinical data were secured and were accessible only to researchers.

Results {#sec1-3}
=======

Between January 2013 and December 2015, 1594 Pap smears were evaluated. Only 38 cases (2.4%) had epithelial cell abnormalities. [Table 1](#T1){ref-type="table"} shows the distribution of evaluated smears and epithelial cell lesions positive smears according to year. More than half (55%) of ECL cases were diagnosed in 2015.

###### 

The Distribution of Evaluated Smears and Epithelial Cell Lesions Positive Smears According to Year

  Year    Number of evaluated smears (%)   Number of ECL smears (%)
  ------- -------------------------------- --------------------------
  2013    490 (30.7%)                      9 (24.3%)
  2014    490 (30.7%)                      8 (21.6%)
  2015    614 (38.5%)                      21 (55%)
  Total   1594                             38

ECL, Epithelial cell lesion

[Table 2](#T2){ref-type="table"} presents the clinical characteristics of female patients included in the study. The mean ages were similar in both study groups:46.7±11.0 years for the case group and 46.9±10.7 years for the control group. While patients in the case group had higher parity compared to patients in the control group (P= 0.021), both groups gave a similar percentage of using an intrauterine contraceptive device (IUCD) and hormones (P= 0.85).

###### 

Clinical Characteristics of Patients with Normal Versus Patients with Abnormal Smears

  Patient characteristics      Case (n=38)   Control (n=77)   OR (95%CI)           P-value
  ---------------------------- ------------- ---------------- -------------------- ---------
  Age, mean± SD                46.7 ± 11.0   46.9 ± 10.7      0.98 (0.39-2.41)     0.921
  Parity, mean± SD             4.5 ± 2.8     3.5 ± 2.3        0.56 (1.14-5.75)     0.021
  IUCD use                     8             15               0.91 (0.35-2.36)     0.845
  Hormones use                 12            23               0.92 (0.39-2.13)     0.851
  Patients symptoms                                                                
   Postcoital bleeding         11            2                15.28 (3.18-73.40)   0
   Postmenopausal bleeding     10            21               0.952 (0.39-2.29)    0.913
   Screen purposes             0             15               0.33 (0.09-1.20)     0.002
   Irregular bleeding          5             8                1.31 (0.39-4.30)     0.659
   Dyspareunia                 4             8                1.02 (0.29-3.61)     0.982
   Vaginal discharge           0             11               0.33 (0.07-1.59)     0.151
   Previous abnormal smear     8             5                3.84 (1.16-12.69)    0.02
   Premenopausal               0             7                0.65 (0.56-0.75)     0.056
  Cervical clinical findings                                                       
   Abnormal appearance         23            25               3.19 (1.42-7.15)     0.004
   Bleeding on touch           5             0                0.30 (0.23-0.39)     0.001
   Erosion                     10            7                3.57 (1.24-10.32)    0.014
   Polyp                       2             3                1.37 (0.22-8.57)     0.735
   Cervicitis                  6             13               0.92 (0.32-2.66)     0.882

IUCD; Intrauterine device

Females who attended the clinics complained of different symptoms. Postmenopausal bleeding was the most common cause leading to clinic attendance at 31 patients (27%), while only 15 (15.7%) came intentionally for screening. Previous abnormal smears had a significant relation with ECL cases (P= 0.020). Case group patients were more likely to present complaints from postcoital bleeding (P\< 0.000), and they were more likely to have an abnormal-looking cervix (P= 0.004); their services bled easily on touch (P= 0.001) and tended to be more eroded (P=0.014).

A total of 23 Pap smears (1.5%) were considered unsatisfactory or inadequate for evaluation. Pathological findings were detected in 1039 smears (65%). Epithelial cell lesions were seen in 38 smears (2.4%). Details of pathological findings are shown in [Table 3](#T3){ref-type="table"}.

###### 

Number and Percentage of the Specific Findings of All the Pap Smears Based on the Bethesda System 2001 with Respect to Mean Age

  Smear result              Mean age ±SD   Number (% of abnormal)
  ------------------------- -------------- ------------------------
  Unsatisfactory                           23 (1.5%)
  Normal                    41.9±9.09      523 (33%)
  ECL                       46.68±11.08    38 (2.4%)
  HSIL                      45.5±10.92     14 (36.8%)
  LSIL                      43.2±10.22     14 (36.8%)
  ASCUS                     47.7±12.01     6 (15.9%)
  Squamous cell carcinoma   50±13.90       2 (5.3%)
  EAC                       80±19.78       1 (2.6%)
  AGC                       69±15.33       1 (2.6%)
  NILM                      41.26±9.01     1010 (63.4%)
  Inflammatory              40.27±8.99     866 ( 86.5%)
  Reactive                  46.10±11.01    20 (1.99%)
  Non specific findings     41.25±9.02     32 (3.19%)
  Atrophy                   54.40±14.32    25 (2.49%)
  Estrogenic influence      39.88±7.55     27 (2.69%)
  Progesterone influence    33.55±8.35     30 (2.99%)
  Cervical ectopy           60.00±20.01    1 (0.09%)
  Total                                    1,594

ECL, Epithelial cell lesion; HSIL, High squamous intraepithelial lesion; LSIL, Low squamous intraepithelial lesion; ASCUS, Atypical squamous cells of undetermined significance; EAC, Endocervical adenocarcinoma; NILM, No intraepithelial lesion or Malignancy.

Discussion {#sec1-4}
==========

The prevalence of ECL in the present study was 2.4%, which is one of the lowest rates of prevalence in KSA, Gulf Cooperation Council (GCC) countries, and other countries. Previous studies from different areas in KSA showed ECL prevalence rates ranging from 1.7% to 17.2% (Al-Kadri et al., 2015; Jamal and Al-Maghrabi, 2003; Al-Jaroudi and Hussain, 2010 and Altaf and Mufti, 2012). Regarding GCC countries, the largest study was carried in Kuwait with an evaluation of 140,404 smears throughout 21 years in which the reported prevalence rate of ECL was 4.3% ([Table 4](#T4){ref-type="table"}) (Kapila et al., 2015).

###### 

Prevalence of the Abnormal Cytological Entities Detected by Cervical Pap Smear in Different Studies

  Study's author   Year   Total number   ECL (n) %       ASCUS (n) %     HSIL (n) %    LSIL (n) %       SSC (n) %   ECA (n) %    AGUS (n) %)
  ---------------- ------ -------------- --------------- --------------- ------------- ---------------- ----------- ------------ ---------------
  Al-Kadri H       2015   19,650         841 (4.30%)     497 (59%))      43 (5.10%)    170 (20.20%)     8 (1%)      21 (2.50%)   53 (6.30%)
  Al-Jaroudi D     2010   241            7 (2.90%)       3 (42.90%)      1 (14.30%)    2 (28.60%)       \-          \-           1 (14.30%)
  Altaf F          2012   7,297          1254 (17.20%)   674 (53.70%)    63 (5%)       198 (15.80%)     4 (0.30%)   \-           \-
  Kapila K         2015   140,404        6013 (4.30%)    3212 (53.40%)   294 (4.90%)   1,279 (21.30%)   118 (2%)    \-           1092 (18.20%)
  Alzaabi M        2015   4,593          225 (4.90%)     114 (64%)       27 (12%)      72 (32%)         2 (0.90%)   \-           5 (2.20%)
  Korkmaz F        2014   3,813          73 (1.90%)      37 (50.70%)     4 (5.50%)     19 (26%)         2 (2.70%)   2 (2.70%)    3 (4.10%)
  CS               2015   1,594          38 (2.40%)      6 (15.90%)      14 (36.80%)   14 (36.80%)      2 (5.30%)   1 (2.60%)    1 (2.60%)

ECL, Epithelial cell lesion; ASCUS, Atypical squamous cells of undetermined significance; HSIL, High squamous intraepithelial lesion; LSIL, Low squamous intraepithelial lesion; SCC, Squamous cells carcinoma; EAC, Endocervical adenocarcinoma; AGUS, Atypical glandular cells of undetermined significant; CS, Current study

In our study, ASCUS was seen in only 6 smears (16.2%) of the epithelial lesions, while LSIL and HSIL were the most frequent lesions, accounting for 36.8% of the total cases for each. In most Saudi studies, ASCUS represented the most common finding (Al-Kadri et al., 2015 and Altaf and Mufti, 2012). Similar studies from United Arab Emirates (UAE) and Turkey reported that ASCUS was the most common category (Alzaabi and Al Muqbali, 2015; Korkmaz and Gencer, 2014).

The mean age of the whole studied population was 41.26 years, and the mean age of the ECL smears was46.68 years, while the means of age in different diagnostic categories of ECL (ASCUS, LSIL, and HSIL) were close but showed a slight increase in patients with cervical cancer. These figures are close to the figures reported in studies from KSA (Al-Kadri et al., 2015 and Altaf and Mufti, 2012) but higher than the figures reported in studies outside KSA (Alzaabi and Al Muqbali, 2015).

The lack of the cervical screening programs in this region is most likely to cause a delay in diagnosis of ECL. This may explain the higher age of patients in this study. [Table 4](#T4){ref-type="table"} lists some studies and their results. Many social themes influence females' perceptions of cervical cancer in KSA. The disease is thought socially to carry the indication of the presence of extramarital sexual relations, which is a social disgrace. This belief has a significant negative impact on the acceptance of females coming for cervical screening (Khan, 2015). The health sector in KSA has made an effort in screening for cervical cancer through some screening programs. The local cervical screening program in Jeddah is one of them (Al-Kadri et al., 2015). The National Cervical screening program has not been implemented yet, and Pap smear screening is still performed on an opportunistic basis during females' visits to health facilities (Al-Kadri et al., 2015).

Using IUCDs was not associated with ECL in our study compared to some studies which linked the use of IUCDs to a higher risk of developing abnormal smears (Yasmin and Mukherjee, 2012) and other studies which showed an inverse relationship of using IUCDs and ECL (Castellsague et al., 2011). Contradicting studies linking the use of hormones with a higher tendency to develop epithelial lesions (Gavric and Takac, 2010), our study revealed an insignificant difference between case and control groups in using the hormone.

Limitation of this study could include the number of evaluated patients and ECL cases, which were considered too low to determine the disease category characteristics. Many studies from KSA had a larger studied population from larger specialized centers, and some of these centers had a local screening program. More patients from previous and coming years should be included to lessen this limitation and determine what was its true prevalence or whether it resulted from a low number of evaluated patients in this region.

This study concluded that the prevalence of cervical epithelial lesions is low if compared to other areas in KSA and other countries. The study highlights that females aged 46.6 years or above harbor the bulk of premalignant and malignant lesions in cervical smears; these females tend to have higher parity and more frequent postcoital bleeding and have an abnormal inspection of cervix uteri. This signifies that these females are among the under-users of cytological screening. Hence, an efficient cervical cancer screening program is needed. More extended studies including assessment of HPV prevalence will be valuable for further exploration of the magnitude of this health problem.
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